Dr. Jinoos Yazdany, MD

Dr. Yazdany practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Yazdany's NPI, 1982632584, was assigned on June 30, 2006. Dr. Yazdany graduated from David Geffen School of Medicine at UCLA in 2000. Dr. Yazdany's California license number on file is A77817.

Dr. Yazdany's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Yazdany's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Yazdany is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Yazdany to 5 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yazdany practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Yazdany's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Yazdany is board certified in rheumatology by the American Board of Internal Medicine. Dr. Yazdany has a license on file in California.

Dmand AI lists arthritis and lupus among the conditions Dr. Yazdany treats.

CMS data shows 28 Medicare services from Dr. Yazdany across 1 procedure code in 2024, for 16 Medicare patients. Medicare paid $414 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 16 Medicare patients who saw Dr. Yazdany in 2024. 69% of them have high cholesterol. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yazdany's median patient age at 65, with 75% women.

In 2024, Dr. Yazdany wrote 284 Medicare Part D claims for 48 patients. 77% of them were for generic drugs. CMS names the drug for 148 of them, across 6 drugs with 11 or more claims each, at $240,428 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Yazdany for performance year 2024, reported as part of a group. Dr. Yazdany accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yazdany as offering telehealth.

Dmand AI links 264 papers to Dr. Yazdany, published from 2008 to 2025. 2024 was the busiest year, with 28. The most frequent topics are Lupus Erythematosus, Systemic, Rheumatology and Arthritis, Rheumatoid. Dr. Yazdany has published most often in Arthritis Care Res (Hoboken). Dr. Yazdany's most frequent co-authors are Gabriela Schmajuk, MD, Lindsey A. Criswell, MD and Cristina M. Lanata, MD.

Dmand AI links Dr. Yazdany to 1 clinical trial. Conditions studied include Rheumatic Diseases and Connective Tissue Diseases.

CMS Open Payments shows 12 general payments to Dr. Yazdany from 4 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $10,350. It also lists 1 research payment totaling $1,406 in 2025.

Dmand AI lists 1 award for Dr. Yazdany.

Dr. Yazdany graduated from David Geffen School of Medicine at UCLA in 2000. Dr. Yazdany is a member of ACR.

Dr. Yazdany is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.